Login

Dedicare - ABGSC Investor Days 8 mars 2022 - Krister Widstrom, CEO, Dedicare AB (publ) 00:00:00

Share On Facebook Share On Twitter

Dedicare - ABGSC Investor Days 8 mars 2022

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Maximizing Charitable Giving and Tax Benefits in Retirement Planning
00:10:00
Unlocking Real Estate ROI: Expert Insights with Boris Dorfman | Boris Dorfman - Fund Manager, LBC Capital
00:10:00
Global Monetary Policy Conference Highlights: Uncommon Knowledge|John Taylor
00:10:00
SafeTruck by Drillco | Sylvain Brisson, Chief Executive at Drillco Mining & Exploration
00:10:00
Fortune Bay Corp: Advancing Gold and Uranium Projects in Saskatchewan and Athabasca Basin
00:10:00
Eurazeo's Strategic Shift: Adapting Amid Sector Dislocations and Embracing Sustainability Goals | Virginie Morgon, CEO, Eurazeo.
00:10:00
HeadHunter Group's NYSE Debut: Behind the Scenes Analysis | Dmitry Sergienkov - Chief Executive Officer of HeadHunter Group plc
00:10:00
musicMagpie CEO Steve Oliver Discusses IPO Success and Future Growth Potential | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Carlyle's Future: Strategic Updates and Investor Confidence Boost | Harvey Schwartz, CEO, Carlyle Group.
00:10:00
The video outlines Axiom's views, emphasizing their potential for change, the risks of investment, and that statements made are for informational purposes only and not guarantees of future performance.
00:10:00
CEO and CFO Presentation at NobleCon17 | Gary Vogel - CEO of Eagle Bulk Shipping Inc.
00:10:00
Special Market Briefing: Growth Companies in Euronext Growth Segment of Borsa Italiana | Nicola Voltan, CEO, Siav Spa.

© 2017 - Neuhu+